Nilotinib in Combination with Carboplatin and Paclitaxel Is a Candidate for Ovarian Cancer Treatment

Publisher： Karger

E-ISSN： 1423-0232|87|4|232-245

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.4, 2014-08, pp. : 232-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sequential Combination of Paclitaxel-Carboplatin and Paclitaxel-Liposomal Doxorubicin as a First-Line Treatment in Patients with Ovarian Cancer

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 348-353

Karger

Access to resources Recommend Favorite

Paclitaxel in Cisplatin or Carboplatin-Pretreated Ovarian Cancer

By  

Oncology, Vol. 55, Iss. 3, 1998-04 ,pp. : 228-234

Karger

Access to resources Recommend Favorite

Gender Differences in Treatment Outcomes among Patients with Non-Small Cell Lung Cancer Given a Combination of Carboplatin and Paclitaxel

By  

Oncology, Vol. 75, Iss. 3-4, 2008-10 ,pp. : 169-174

Karger

Access to resources Recommend Favorite

Carboplatin and Paclitaxel Treatment Is Effective in Advanced Anal Cancer

By  

Oncology, Vol. 87, Iss. 2, 2014-07 ,pp. : 125-132

Karger

Access to resources Recommend Favorite

Case of pure ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin but responsive to monotherapy with weekly irinotecan

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 5, 2015-05 ,pp. : 809-812

John Wiley & Sons Inc

Access to resources Recommend Favorite